Kliniske studier for Migrene i Pennsylvania
8 studier for Migrene søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 1
Alder 6 til 11 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06995729MMA Embolization for Refractory Chronic Migraine
- Thomas Jefferson University Hospital, Philadelphia
Rekrutterer
Alder 18 til 65 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06735833Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Clario, Philadelphia
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 24. sep. 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- The Children's Hospital of Philadelphia /ID# 270842, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 270854, Scottdale
- Frontier Clinical Research - Smithfield /ID# 270849, Smithfield
RekruttererFase 3
Alder 12 til 17 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Children's Hospital of Philadelphia, Philadelphia
Rekrutterer
Alder 10 til 17 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- University of Pennsylvania, Philadelphia
RekruttererFase 4
Alder 18 til 70 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Children's Hospital of Philadelphia - Main /ID# 232487, Philadelphia
- Frontier Clinical Research - Scottdale /ID# 231913, Scottdale
- Frontier Clinical Research - Smithfield /ID# 231912, Smithfield
RekruttererFase 3
Alder 6 til 17 · Alle kjønn · Oppdatert 14. sep. 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Lehigh Center for Clinical Research, Allentown
- Clinical Research Philadelphia, Philadelphia
- Preferred Primary Care Physicians, Inc., Pittsburgh
- og 2 flere
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07645924Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.